CARD ID | 132 | |
Type of strain | Targeted mutant. | |
Strain name | B6.129P2-Irf2tm1Oci | |
Internal Code | B6.129p2-Irf2tm1 N16 | |
Submitter | Shigeo Koyasu | |
Submitter affiliation or code | RIKEN | |
Stock Type | ||
Material Transfer Conditions |
Consent to us
|
|
Production method | From other organizations | |
Origin (In-house) | Organization | |
Organization code | ||
Developer | ||
Origin (From other organizations) | Organization | Ontario Cancer Institute |
Organization code | Oci | |
Developer | Tak W. Mak | |
Year introduced | 1998 | |
Introduced Generation | ||
Remarks |
Gene symbol | Irf2 |
Gene name | Interferon regulatory factor2 |
Allele symbol | |
Allele name | |
MGI | MGI:96591, |
Chromosome | Unknown , |
Gene classification | Targeted or trapped gene(knockout etc.) |
Method | |
OMIM | OMIM ID: 147576 Human Gene Symbol: IRF2, |
Author | Toshifumi Matsuyama, Tohru Kimura, Motoo Kitagawa, Klaus Pfeffer, Takatoshi Kawakami, Nobumasa Watanabe, Thomas M. Kundig, Ryuichi Amakawa, Kenji Kishihara, Andrew Wakeham, Julia Potter, Caren L. Furlonger, Arumugavadivel Narendran, Haruhiko Suzuki, Pamela S. Ohashi, Christopher J. Paige, Tadatsugu Taniguchi, and Tak W. Mak |
Title | Targeted Disruption of IRF-1 or IRF-2 Results in Abnormal Type I IFN Gene Induction and Aberrant Lymphocyte Development |
Journal | Cell |
Volume | 75 |
Page | 83-97 |
Year | 1993 |
PMID | 8402903 |
Disease name, Applicable field |